Small-Molecule Antibiotic Drug Development
A special issue of Targets (ISSN 2813-3137).
Deadline for manuscript submissions: 20 December 2025 | Viewed by 2246
Special Issue Editor
Interests: organic chemistry; organic synthesis; medicinal chemistry; methodology development; antibiotics; nanotechnology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Bacterial infections constitute one of the major cases of primary medical incidences worldwide. Historically, the fight against bacterial infections in humans has been an ongoing battle due to the ability of bacteria to adapt and to survive. After a century of engagement in the fight against bacterial infections, the scientific community continues to intensively search for new therapeutic agents, especially those active against resistant bacteria.
In this Special Issue, we are looking for all kinds of articles regarding the development of antibiotics based on small molecules. From the synthetic to the medical community, going through biological studies of new mechanisms of action, we aim to collect interesting and novel ideas around antibiotic drug discovery. In addition, we open the door to new technologies and treatments to overcome the classical resistance exhibited by bacteria.
Dr. Miguel Garcia-Castro
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Targets is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- small molecules
- antibiotic drug discovery
- bacterial infections
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
